Chinese biotech firm Immunotech deploys IPO cash to bet on next technology to fight liver cancer

, , Comments Off on Chinese biotech firm Immunotech deploys IPO cash to bet on next technology to fight liver cancer

Beijing in 2016 required them to go through clinical trials … after raising HK$1 billion from an initial public offering in June. The IPO, under Hong Kong’s two year-old regime that allowed …
( read original story …)